7 articles
Isomorphic Labs unveiled IsoDDE, an AI drug design engine that more than doubles AlphaFold 3's accuracy in protein-ligand prediction and identifies novel binding pockets from sequence alone, as the company prepares for its first clinical trials.
Google DeepMind open-sourced AlphaGenome, an AI model published in Nature that predicts DNA function across 1 million base pairs, already used by nearly 3,000 scientists worldwide for cancer and disease research.
Hologen, co-founded by former Google CEO Eric Schmidt, is raising $150M at an $850M valuation, combining AI drug development with a $430M MeiraGTx gene therapy partnership for Parkinson's disease.
Chai Discovery raised $130M at a $1.3B valuation in December 2025, backed by OpenAI and others, after unveiling Chai-2 with a 100x improvement in zero-shot de novo antibody design and a 16% hit rate.
Intro AI has rapidly evolved from science fiction into a practical tool accelerating real scientific breakthroughs. In laboratories and research centers around the world, AI systems are crunching data, designing experiments, and even formulating...
Exhibit A Profluent has announced their new family of foundation models for protein generation, the ProGen3 series. Whether you’re looking to understand their methods and findings, or simply curious on what the heck a protein language model is ––...
Sprintome is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. From foundation models like Evo 2 and Alphafold 3 to synthetic data generation and agentic AI workflows — Next‑gen AI...